{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:54Z","timestamp":1786120374284,"version":"build-2736575974"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,5,15]]},"DOI":"10.1097\/qad.0b013e328351f7a5","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T04:28:29Z","timestamp":1329193709000},"page":"909-919","source":"Crossref","is-referenced-by-count":36,"title":["Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity"],"prefix":"10.1097","volume":"26","author":[{"given":"Giovanni","family":"Barillari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Iovane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bacigalupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Palladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Monini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ensoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000214918","article-title":"Molecular mechanisms of human papillomavirus-induced carcinogenesis.","volume":"12","author":"Lehoux","year":"2009","journal-title":"Public Health Genomics"},{"key":"R2-2-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2009.09.033","article-title":"Antiangiogenesis agents in metastatic or recurrent cervical cancer.","volume":"116","author":"Monk","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R3-2-20210130","first-page":"6537","article-title":"Increased expression and activation of gelatinolytic matrix metalloproteinases is associated with the progression and recurrence of human cervical cancer.","volume":"63","author":"Sheu","year":"2003","journal-title":"Cancer Res"},{"key":"R4-2-20210130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/ijgc-00009577-200403000-00021","article-title":"Matrix metalloproteinases-2, -3, and -9 secreted by explants of benign and malignant lesions of the uterine cervix.","volume":"14","author":"Arguello-Ramirez","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"R5-2-20210130","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/gyno.1998.5285","article-title":"Expression of matrix metalloproteinase-9 in squamous cell carcinoma of the uterine cervix-clinicopathologic study using immunohistochemistry and mRNA in situ hybridization.","volume":"72","author":"Davidson","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R6-2-20210130","first-page":"199","article-title":"Expression of matrix metalloproteinase-2 in preinvasive and invasive carcinoma of the uterine cervix.","volume":"26","author":"Nasr","year":"2005","journal-title":"Gynaecol Oncol"},{"key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijgo.2005.08.021","article-title":"Matrix metalloproteinase 9 in the uterine cervix during tumor progression.","volume":"92","author":"Talvensaari-Mattila","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"R8-2-20210130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/1933719107307916","article-title":"A significant elevation of plasma level of matrix metalloproteinase-9 in patients with high-grade intraepithelial neoplasia and early squamous cell carcinoma of the uterine cervix.","volume":"14","author":"Yang","year":"2007","journal-title":"Reprod Sci"},{"key":"R9-2-20210130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.23487","article-title":"Cancer risk in people infected with human immunodeficiency virus in the United States.","volume":"123","author":"Engels","year":"2008","journal-title":"Int J Cancer"},{"key":"R10-2-20210130","first-page":"36","article-title":"Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy.","volume":"78","author":"Soncini","year":"2007","journal-title":"Acta Biomed"},{"key":"R11-2-20210130","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/00002030-199812000-00007","article-title":"Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.","volume":"12","author":"Heard","year":"1998","journal-title":"AIDS"},{"key":"R12-2-20210130","first-page":"277","article-title":"Screening and management of precancerous lesions to prevent cervical cancer in low-resource settings.","volume":"4","author":"Sellors","year":"2003","journal-title":"Asian Pac J Cancer Prev"},{"key":"R13-2-20210130","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/00002030-200111090-00011","article-title":"The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.","volume":"15","author":"Minkoff","year":"2001","journal-title":"AIDS"},{"key":"R14-2-20210130","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QAD.0b013e328340fd99","article-title":"Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.","volume":"25","author":"Omar","year":"2011","journal-title":"AIDS"},{"key":"R16-2-20210130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1368-7646(03)00060-8","article-title":"HIV protease inhibitors as new treatment options for Kaposis sarcoma.","volume":"6","author":"Barillari","year":"2003","journal-title":"Drug Resist Updat"},{"key":"R17-2-20210130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1470-2045(03)01192-6","article-title":"Use of HIV protease inhibitors to block Kaposis sarcoma and tumour growth.","volume":"4","author":"Sgadari","year":"2003","journal-title":"Lancet Oncol"},{"key":"R18-2-20210130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jac\/dkg086","article-title":"HIV protease inhibitors: antiretroviral agents with anti-inflammatory, antiangiogenic and antitumour activity.","volume":"51","author":"Monini","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"R19-2-20210130","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrc1479","article-title":"Antitumour effects of antiretroviral therapy.","volume":"4","author":"Monini","year":"2004","journal-title":"Nature Rev Cancer"},{"key":"R20-2-20210130","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1517\/14656566.2011.577066","article-title":"Pharmacological management of Kaposis sarcoma.","volume":"12","author":"Sgadari","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"R21-2-20210130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nm0302-225","article-title":"HIV protease inhibitors are potent antiangiogenic molecules and promote regression of Kaposi sarcoma.","volume":"8","author":"Sgadari","year":"2002","journal-title":"Nature Med"},{"key":"R22-2-20210130","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/1078-0432.CCR-05-2188","article-title":"Evaluation of antitumoral properties of the protease inhibitor indinavir in a murine model of hepatocarcinoma.","volume":"12","author":"Esposito","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R23-2-20210130","first-page":"125","article-title":"Effects of indinavir in a preliminary phase I study on dogs with stage III slenic hemangiosarcoma.","volume":"20","author":"Spugnini","year":"2006","journal-title":"In Vivo"},{"key":"R24-2-20210130","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-8-26","article-title":"Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells.","volume":"8","author":"Kumar","year":"2009","journal-title":"Molec Cancer"},{"key":"R25-2-20210130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ijc.25550","article-title":"Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via a proteasome-independent block of angiogenesis and matrix metalloproteinases.","volume":"128","author":"Toschi","year":"2011","journal-title":"Int J Cancer"},{"key":"R26-2-20210130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1470-2045(08)70334-6","article-title":"Anti-HIV drugs for cancer therapeutics: back to the future.","volume":"10","author":"Chow","year":"2009","journal-title":"Lancet Oncol"},{"key":"R27-2-20210130","first-page":"6901","article-title":"Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.","volume":"62","author":"Gaedicke","year":"2002","journal-title":"Cancer Res"},{"key":"R28-2-20210130","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1158\/1535-7163.MCT-07-2375","article-title":"Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis.","volume":"7","author":"Kraus","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"R29-2-20210130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/135965350501000203","article-title":"The HIV protease inhibitors nelfinavir and saquinavir, but not a variety of HIV reverse transcriptase inhibitors, adversely affect human proteasome function.","volume":"10","author":"Piccinini","year":"2005","journal-title":"Antivir Ther"},{"key":"R30-2-20210130","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/QAD.0b013e3283262a8d","article-title":"Clinical course of classic Kaposis sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir.","volume":"23","author":"Monini","year":"2009","journal-title":"AIDS"},{"key":"R31-2-20210130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.virol.2007.12.011","article-title":"Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding.","volume":"374","author":"Wooldridge","year":"2008","journal-title":"Virology"},{"key":"R32-2-20210130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/MMBR.68.2.362-372.2004","article-title":"Pathogenesis of human papillomaviruses in differentiating epithelia.","volume":"68","author":"Longworth","year":"2004","journal-title":"Microb Mol Biol Rev"},{"key":"R33-2-20210130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/1471-2407-11-477","article-title":"Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.","volume":"11","author":"Apraiz","year":"2011","journal-title":"BMC Cancer"},{"key":"R34-2-20210130","first-page":"17","article-title":"Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine.","volume":"62","author":"Nakano","year":"2009","journal-title":"J Antimicrob"},{"key":"R35-2-20210130","first-page":"165","article-title":"Protease inhibitor plasma concentrations in HIV antiretroviral therapy.","volume":"55","author":"Justesen","year":"2008","journal-title":"Dan Med Bull"},{"key":"R36-2-20210130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1159\/000030043","article-title":"Factors regulating SCC antigen expression in squamous cell carcinoma of the uterine cervix.","volume":"19","author":"Maruo","year":"1998","journal-title":"Tumour Biol"},{"key":"R37-2-20210130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/brain\/awh049","article-title":"Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia.","volume":"127","author":"Liuzzi","year":"2004","journal-title":"Brain"},{"key":"R38-2-20210130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1139\/o06-084","article-title":"Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence.","volume":"84","author":"da Silva Cardeal","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"R39-2-20210130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1139\/o06-084","article-title":"Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence.","volume":"84","author":"da Silva Cardeal","year":"2006","journal-title":"Biochem Cell Biol"},{"key":"R40-2-20210130","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/135965350601100607","article-title":"Specific HIV protease inhibitors inhibit the ability of HPV16 E6 to degrade p53 and selectively kill E6-dependent cervical carcinoma cells in vitro.","volume":"11","author":"Hampson","year":"2006","journal-title":"Antivir Ther"},{"key":"R41-2-20210130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.2001.6573","article-title":"Antiinvasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.","volume":"85","author":"Iwasaki","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R42-2-20210130","first-page":"565","article-title":"Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.","volume":"9","author":"Kato","year":"2002","journal-title":"Oncol Rep"},{"key":"R43-2-20210130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-9378-5-2","article-title":"Rapid, sensitive, type specific PCR detection of the E7 region of human papillomavirus type 16 and 18 from paraffin embedded sections of cervical carcinoma.","volume":"5","author":"Lesnikova","year":"2010","journal-title":"Infect Agent Cancer"},{"key":"R44-2-20210130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1189\/jlb.0205112","article-title":"Interferon-gamma-activated STAT-1alpha suppresses MMP-9 gene transcription by sequestration of the coactivators CBPp300.","volume":"78","author":"Ma","year":"2005","journal-title":"J Leukoc Biol"},{"key":"R45-2-20210130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1172\/JCI200422087","article-title":"An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.","volume":"114","author":"Giraudo","year":"2004","journal-title":"J Clin Invest"},{"key":"R46-2-20210130","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/ijc.23684","article-title":"A robust ex vivo model for evaluation of induction of apoptosis by rhTRAIL in combination with proteasome inhibitor MG132 in human premalignant cervical explants.","volume":"123","author":"Hougardy","year":"2008","journal-title":"Int J Cancer"},{"key":"R47-2-20210130","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.","volume":"11","author":"Chen","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"R48-2-20210130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting.","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J"},{"key":"R49-2-20210130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1387\/ijdb.041811af","article-title":"Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.","volume":"48","author":"Folgueras","year":"2004","journal-title":"Int J Dev Biol"},{"key":"R50-2-20210130","doi-asserted-by":"crossref","first-page":"C1482","DOI":"10.1152\/ajpcell.00038.2004","article-title":"Indinavir impairs protein synthesis and phosphorylations of MAPKs in mouse C2C12 myocytes.","volume":"287","author":"Hong-Brown","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"R51-2-20210130","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1158\/0008-5472.CAN-05-1220","article-title":"HIV protease inhibitors block Akt signalling and radiosensitize tumor cells both in vitro and in vivo.","volume":"65","author":"Gupta","year":"2005","journal-title":"Cancer Res"},{"key":"R52-2-20210130","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1038\/onc.2010.613","article-title":"Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53microRNA-23burokinase-type plasminogen activator pathway.","volume":"30","author":"Au Yeung","year":"2011","journal-title":"Oncogene"},{"key":"R55-2-20210130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.","volume":"97","author":"Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R56-2-20210130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/01.qco.0000200295.30285.13","article-title":"AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.","volume":"19","author":"Bower","year":"2006","journal-title":"Curr Opin Infect Dis"},{"key":"R57-2-20210130","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.bjc.6604923","article-title":"Pattern of cancer risk in persons with AIDS in Italy in the HAART era.","volume":"100","author":"Dal Maso","year":"2009","journal-title":"Br J Cancer"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201205150-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:38:40Z","timestamp":1786048720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201205150-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328351f7a5","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,15]]}}}